Selected article for: "antiviral therapy and care unit"
Author: Rello, Jordi; Belliato, Mirko; Dimopoulos, Meletios-Athanasios; Giamarellos-bourboulis, Evangelos J.; Jaksic, Vladimir; Martin-loeches, Ignacio; Mporas, Iosif; Pelosi, Paolo; Poulakou, Garyphallia; Pournaras, Spyridon; Tamae-kakazu, Maximiliano; Timsit, Jean-François; Waterer, Grant; Tejada, Sofia; Dimopoulos, George
Title: Update in COVID-19 in the Intensive Care Unit from the 2020 HELLENIC Athens International Symposium
  • Cord-id: 960xqft4
  • Document date: 2020_10_22
    • ID: 960xqft4
    Snippet: The 2020 International Web Scientific Event in COVID-19 pandemic in critically ill patients aimed at updating the information and knowledge on the COVID-19 pandemic in the intensive care unit. Experts reviewed the latest literature relating to the COVID-19 pandemic in critically ill patients, such as epidemiology, pathophysiology, phenotypes of infection, COVID-19 as a systematic infection, molecular diagnosis, mechanical ventilation, thromboprophylaxis, COVID-19 associated co-infections, immuno
    Document: The 2020 International Web Scientific Event in COVID-19 pandemic in critically ill patients aimed at updating the information and knowledge on the COVID-19 pandemic in the intensive care unit. Experts reviewed the latest literature relating to the COVID-19 pandemic in critically ill patients, such as epidemiology, pathophysiology, phenotypes of infection, COVID-19 as a systematic infection, molecular diagnosis, mechanical ventilation, thromboprophylaxis, COVID-19 associated co-infections, immunotherapy, plasma treatment, Catheter-Related bloodstream infections, artificial intelligence for COVID-19, and vaccination. Antiviral therapy and co-infections are out of the scope of this review. In this review, each of these issues is discussed with key messages regarding management and further research being presented after a brief review of available evidence.

    Search related documents:
    Co phrase search for related documents
    • abnormal activation and acute infection: 1, 2
    • abnormal activation and acute phase: 1
    • abnormal activation and acute respiratory failure: 1, 2, 3
    • abnormal activation and lung alveolar: 1, 2
    • abnormal activation and lung disease: 1, 2, 3, 4, 5
    • abnormal activation and macrophage activation: 1
    • accurate rapid and acute ards respiratory distress syndrome: 1, 2, 3
    • accurate rapid and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • accurate rapid and acute phase: 1, 2
    • accurate rapid and acute respiratory failure: 1, 2
    • accurate rapid and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • accurate rapid and lung region: 1, 2
    • accurate rapid and lung tissue: 1
    • accurate rapid early and acute ards respiratory distress syndrome: 1
    • accurate rapid early and lung disease: 1